Alterity Therapeutics Ltd at GCFF Global Chinese Financial Conference -- Healthcare Investment North America (Virtual) Transcript
Good morning, everyone. Thank you, Gilbert. Ni hao to our Chinese-speaking participants and thank you for the opportunity to present the great work that we're doing at Alterity Therapeutics. My name is David Stamler. I'm the CEO of Alterity. And I wanted to -- I look forward to telling you about the work that we're trying to -- that we're doing to help patients.
These are our forward-looking statements. And I'd advise you to consult our regulatory documents. As Gilbert mentioned, Alterity is dedicated to creating an alternate future for patients with neurodegenerative diseases. Now, our name itself, Alterity, means the state of being different. And we really want to change the arc of people's lives with these diseases and to modify the course of disease.
Our strategy is to target the underlying pathology of disease. And this is a common goal within neuro -- treating neurodegenerative diseases, but no one has been successful yet. We have a strong and highly experienced management team, including three drug approvals through the FDA. Our lead
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
